Administration options for pegfilgrastim prophylaxis: patient and physician preferences from a cross-sectional survey

Hauber A. Brett; Mange Brennan; Price Mark A.; Wolin Daniel; Bensink Mark; Kaye James A.; Chandler David

首页> 外文期刊>Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer >Administration options for pegfilgrastim prophylaxis: patient and physician preferences from a cross-sectional survey

【24h】

Administration options for pegfilgrastim prophylaxis: patient and physician preferences from a cross-sectional survey

机译：PEGFILGRASTIM预防的管理选择：剖视调查的患者和医师偏好

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Although clinical guidelines recommend administration of pegfilgrastim 1-4 days after a myelosuppressive chemotherapy cycle to decrease the incidence of febrile neutropenia (FN), some physicians administer pegfilgrastim on the same day as chemotherapy administration. A novel on-body injector (OBI) that automatically delivers pegfilgrastim the day after chemotherapy is also available. Our objective was to estimate patient and physician preferences among the pegfilgrastim administration options.

机译：虽然临床指南建议在骨髓抑制化疗循环后1-4天施用PEGFILGRASTIM 1-4天，但是一些医生在同一天施用PEGFILGRASTIM作为化疗给药。一部新型的体内注射器（OBI），在化疗后的一天可以自动提供PegfilGrastim。我们的目标是在PEGFILGRASTIM管理选择中估算患者和医生偏好。

著录项

来源
《Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer》 |2018年第1期|共10页
作者
Hauber A. Brett; Mange Brennan; Price Mark A.; Wolin Daniel; Bensink Mark; Kaye James A.; Chandler David;
展开▼
作者单位

RTI Hlth Solut Res Triangle Pk NC 27703 USA;

RTI Hlth Solut Res Triangle Pk NC 27703 USA;

RTI Hlth Solut Res Triangle Pk NC 27703 USA;

RTI Hlth Solut Ann Arbor MI USA;

Amgen Inc Thousand Oaks CA 91320 USA;

RTI Hlth Solut Waltham MA USA;

Amgen Inc Thousand Oaks CA 91320 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类护理学;
关键词
Pegfilgrastim; Febrile neutropenia; Preference; Patient; Physician;

机译：Pegfilgrastim;Febrile Neveropenia;偏好;患者;医生;

相似文献

外文文献
中文文献
专利

1. Administration options for pegfilgrastim prophylaxis: patient and physician preferences from a cross-sectional survey [J] . Hauber A. Brett, Mange Brennan, Price Mark A., Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer . 2018,第1期

机译：PEGFILGRASTIM预防的管理选择：剖视调查的患者和医师偏好
2. Physician and patient perceptions of the route of administration of venous thromboembolism prophylaxis: Results from an international survey [J] . CimminielloC., AndersonJr.F.A. Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis . 2012,第2期

机译：医师和患者对静脉血栓栓塞预防途径的认识：一项国际调查的结果
3. Factors associated with a preference for disclosure of life expectancy information from physicians: a cross-sectional survey of cancer patients undergoing radiation therapy [J] . Uchida Megumi, Sugie Chikao, Yoshimura Michio, Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer . 2019,第12期

机译：与医生披露预期寿命信息的偏好相关的因素：癌症患者接受放射治疗的横断面调查
4. HPV Knowledge Among Physicians and Their Low-Income Patients: Survey Findings and Approaches for Change [C] . S. Sheinfeld Gorin, R. Franco, C. Westhof International Multidisciplinary Congress . 2006

机译：医生和他们的低收入患者的HPV知识：调查结果和变革方法
5. Cross-sectional survey on disease severity in Japanese patients with harlequin ichthyosis/ichthyosis: Syndromic forms and quality-of-life analysis in a subgroup [D] . Murase Chiaki, 村瀬千晶 2019

机译：日本丑角鱼鳞病/鱼鳞病患者疾病严重程度的横断面调查：亚组的症状形式和生活质量分析
6. Risk of chemotherapy-induced febrile neutropenia in cancer patients receiving pegfilgrastim prophylaxis: does timing of administration matter? [O] . Derek Weycker, Xiaoyan Li, Jacqueline Figueredo, -1

机译：接受聚吡非司亭预防的癌症患者化疗引起的发热性中性粒细胞减少的风险：给药时间重要吗？
7. Patient, nurse, and physician preferences: final results of the CONVENIENCE study evaluating pegfilgrastim prophylaxis via pre-filled syringe or on-body injector in cancer patients [O] . Michael Metz, Dieter Semsek, Gunther Rogmans, 2021

机译：患者，护士和医生偏好：方便研究的最终结果通过预填充注射器或癌症患者的身体注射器评估PegfilGrastim预防

Administration options for pegfilgrastim prophylaxis: patient and physician preferences from a cross-sectional survey

摘要

著录项

相似文献

相关主题

期刊订阅